STERIS plc (STE)
USD 212.76
(0.07%)
USD 212.76
(0.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 11.06 Billion USD | 2.23% |
| 2023 | 10.82 Billion USD | -5.51% |
| 2022 | 11.45 Billion USD | 74.2% |
| 2021 | 6.57 Billion USD | 21.18% |
| 2020 | 5.42 Billion USD | 6.95% |
| 2019 | 5.07 Billion USD | -2.45% |
| 2018 | 5.2 Billion USD | 5.6% |
| 2017 | 4.92 Billion USD | -7.89% |
| 2016 | 5.34 Billion USD | 154.66% |
| 2015 | 2.09 Billion USD | 11.25% |
| 2014 | 1.88 Billion USD | 7.16% |
| 2013 | 1.76 Billion USD | 25.28% |
| 2012 | 1.4 Billion USD | -1.47% |
| 2011 | 1.42 Billion USD | 15.2% |
| 2010 | 1.23 Billion USD | 1.76% |
| 2009 | 1.21 Billion USD | -1.8% |
| 2008 | 1.23 Billion USD | 2.49% |
| 2007 | 1.2 Billion USD | 1.7% |
| 2006 | 1.18 Billion USD | 0.27% |
| 2005 | 1.18 Billion USD | 10.83% |
| 2004 | 1.06 Billion USD | 19.53% |
| 2003 | 894.99 Million USD | 6.35% |
| 2002 | 841.57 Million USD | -0.4% |
| 2001 | 844.98 Million USD | -6.48% |
| 2000 | 903.57 Million USD | 4.34% |
| 1999 | 866 Million USD | 18.25% |
| 1998 | 732.32 Million USD | 35.74% |
| 1997 | 539.5 Million USD | 531.73% |
| 1996 | 85.4 Million USD | 55.56% |
| 1995 | 54.9 Million USD | 28.57% |
| 1994 | 42.7 Million USD | 38.19% |
| 1993 | 30.9 Million USD | 286.25% |
| 1992 | 8 Million USD | 81.82% |
| 1991 | 4.4 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 11.43 Billion USD | 1.37% |
| 2024 Q1 | 10.78 Billion USD | -0.35% |
| 2024 Q2 | 11.28 Billion USD | 4.6% |
| 2024 Q4 | 11.06 Billion USD | -3.25% |
| 2024 FY | 11.06 Billion USD | 2.23% |
| 2023 Q3 | 10.79 Billion USD | 2.96% |
| 2023 FY | 10.82 Billion USD | -5.51% |
| 2023 Q4 | 10.82 Billion USD | 0.2% |
| 2023 Q2 | 10.48 Billion USD | -6.24% |
| 2023 Q1 | 11.18 Billion USD | -2.31% |
| 2022 Q4 | 11.45 Billion USD | -2.03% |
| 2022 Q2 | 11.75 Billion USD | -2.88% |
| 2022 Q1 | 12.1 Billion USD | 84.06% |
| 2022 FY | 11.45 Billion USD | 74.2% |
| 2022 Q3 | 11.68 Billion USD | -0.53% |
| 2021 FY | 6.57 Billion USD | 21.18% |
| 2021 Q3 | 6.58 Billion USD | 19.81% |
| 2021 Q4 | 6.57 Billion USD | -0.1% |
| 2021 Q1 | 5.36 Billion USD | -1.14% |
| 2021 Q2 | 5.49 Billion USD | 2.4% |
| 2020 Q3 | 5.33 Billion USD | 2.89% |
| 2020 Q2 | 5.18 Billion USD | -0.84% |
| 2020 Q1 | 5.22 Billion USD | 3.09% |
| 2020 Q4 | 5.42 Billion USD | 1.69% |
| 2020 FY | 5.42 Billion USD | 6.95% |
| 2019 Q1 | 5.05 Billion USD | -2.86% |
| 2019 Q4 | 5.07 Billion USD | 1.33% |
| 2019 FY | 5.07 Billion USD | -2.45% |
| 2019 Q2 | 5.02 Billion USD | -0.6% |
| 2019 Q3 | 5 Billion USD | -0.3% |
| 2018 Q1 | 5.05 Billion USD | 2.67% |
| 2018 Q3 | 5.15 Billion USD | 0.72% |
| 2018 Q4 | 5.2 Billion USD | 0.84% |
| 2018 FY | 5.2 Billion USD | 5.6% |
| 2018 Q2 | 5.12 Billion USD | 1.27% |
| 2017 Q1 | 5.29 Billion USD | -1.0% |
| 2017 Q3 | 4.88 Billion USD | -6.21% |
| 2017 Q4 | 4.92 Billion USD | 0.77% |
| 2017 FY | 4.92 Billion USD | -7.89% |
| 2017 Q2 | 5.21 Billion USD | -1.56% |
| 2016 Q2 | 2.3 Billion USD | 5.85% |
| 2016 Q1 | 2.18 Billion USD | 3.9% |
| 2016 Q3 | 5.35 Billion USD | 131.71% |
| 2016 Q4 | 5.34 Billion USD | -0.07% |
| 2016 FY | 5.34 Billion USD | 154.66% |
| 2015 Q2 | 2.02 Billion USD | -1.22% |
| 2015 FY | 2.09 Billion USD | 11.25% |
| 2015 Q1 | 2.05 Billion USD | 8.76% |
| 2015 Q4 | 2.09 Billion USD | 3.53% |
| 2015 Q3 | 2.02 Billion USD | 0.02% |
| 2014 Q3 | 1.77 Billion USD | -0.6% |
| 2014 Q2 | 1.78 Billion USD | 0.81% |
| 2014 Q4 | 1.88 Billion USD | 6.15% |
| 2014 Q1 | 1.77 Billion USD | 0.74% |
| 2014 FY | 1.88 Billion USD | 7.16% |
| 2013 Q2 | 1.63 Billion USD | 16.35% |
| 2013 FY | 1.76 Billion USD | 25.28% |
| 2013 Q3 | 1.76 Billion USD | 8.11% |
| 2013 Q4 | 1.76 Billion USD | -0.22% |
| 2013 Q1 | 1.4 Billion USD | -0.17% |
| 2012 FY | 1.4 Billion USD | -1.47% |
| 2012 Q4 | 1.4 Billion USD | 2.13% |
| 2012 Q3 | 1.37 Billion USD | 0.3% |
| 2012 Q2 | 1.37 Billion USD | -3.15% |
| 2012 Q1 | 1.41 Billion USD | -0.69% |
| 2011 Q3 | 1.35 Billion USD | 4.48% |
| 2011 FY | 1.42 Billion USD | 15.2% |
| 2011 Q1 | 1.26 Billion USD | 2.2% |
| 2011 Q2 | 1.29 Billion USD | 2.28% |
| 2011 Q4 | 1.42 Billion USD | 5.49% |
| 2010 Q2 | 1.26 Billion USD | 3.95% |
| 2010 FY | 1.23 Billion USD | 1.76% |
| 2010 Q4 | 1.23 Billion USD | -4.42% |
| 2010 Q3 | 1.29 Billion USD | 2.57% |
| 2010 Q1 | 1.21 Billion USD | -0.14% |
| 2009 Q3 | 1.19 Billion USD | -6.26% |
| 2009 Q1 | 1.21 Billion USD | -2.01% |
| 2009 FY | 1.21 Billion USD | -1.8% |
| 2009 Q4 | 1.21 Billion USD | 1.84% |
| 2009 Q2 | 1.27 Billion USD | 4.96% |
| 2008 FY | 1.23 Billion USD | 2.49% |
| 2008 Q1 | 1.18 Billion USD | -1.76% |
| 2008 Q2 | 1.2 Billion USD | 1.36% |
| 2008 Q3 | 1.19 Billion USD | -0.77% |
| 2008 Q4 | 1.23 Billion USD | 3.72% |
| 2007 Q1 | 1.19 Billion USD | 0.62% |
| 2007 FY | 1.2 Billion USD | 1.7% |
| 2007 Q4 | 1.2 Billion USD | 3.62% |
| 2007 Q3 | 1.16 Billion USD | 0.21% |
| 2007 Q2 | 1.16 Billion USD | -2.66% |
| 2006 Q1 | 1.14 Billion USD | -3.67% |
| 2006 Q4 | 1.18 Billion USD | 5.28% |
| 2006 FY | 1.18 Billion USD | 0.27% |
| 2006 Q3 | 1.12 Billion USD | -2.37% |
| 2006 Q2 | 1.15 Billion USD | 1.28% |
| 2005 Q3 | 1.11 Billion USD | 4.66% |
| 2005 FY | 1.18 Billion USD | 10.83% |
| 2005 Q1 | 1.05 Billion USD | -1.25% |
| 2005 Q2 | 1.06 Billion USD | 1.18% |
| 2005 Q4 | 1.18 Billion USD | 5.99% |
| 2004 Q3 | 997.75 Million USD | 4.04% |
| 2004 FY | 1.06 Billion USD | 19.53% |
| 2004 Q1 | 962.4 Million USD | 7.53% |
| 2004 Q2 | 959.04 Million USD | -0.35% |
| 2004 Q4 | 1.06 Billion USD | 7.22% |
| 2003 Q2 | 842.56 Million USD | 0.9% |
| 2003 Q4 | 894.99 Million USD | 5.78% |
| 2003 Q1 | 835.01 Million USD | -0.78% |
| 2003 Q3 | 846.06 Million USD | 0.42% |
| 2003 FY | 894.99 Million USD | 6.35% |
| 2002 FY | 841.57 Million USD | -0.4% |
| 2002 Q4 | 841.57 Million USD | 2.68% |
| 2002 Q2 | 816.43 Million USD | 0.68% |
| 2002 Q3 | 819.63 Million USD | 0.39% |
| 2002 Q1 | 810.9 Million USD | -4.03% |
| 2001 Q3 | 864.19 Million USD | -1.59% |
| 2001 FY | 844.98 Million USD | -6.48% |
| 2001 Q4 | 844.98 Million USD | -2.22% |
| 2001 Q1 | 872.25 Million USD | -3.47% |
| 2001 Q2 | 878.14 Million USD | 0.68% |
| 2000 Q1 | 865.8 Million USD | -0.02% |
| 2000 Q4 | 903.57 Million USD | -1.77% |
| 2000 Q2 | 905.4 Million USD | 4.57% |
| 2000 FY | 903.57 Million USD | 4.34% |
| 2000 Q3 | 919.9 Million USD | 1.6% |
| 1999 Q2 | 825 Million USD | 10.88% |
| 1999 FY | 866 Million USD | 18.25% |
| 1999 Q1 | 744.03 Million USD | 1.6% |
| 1999 Q4 | 866 Million USD | 1.56% |
| 1999 Q3 | 852.7 Million USD | 3.36% |
| 1998 Q4 | 732.32 Million USD | -0.16% |
| 1998 Q1 | 538.98 Million USD | -0.09% |
| 1998 Q2 | 723.55 Million USD | 34.24% |
| 1998 Q3 | 733.49 Million USD | 1.37% |
| 1998 FY | 732.32 Million USD | 35.74% |
| 1997 Q1 | 557.6 Million USD | 552.93% |
| 1997 Q2 | 479.9 Million USD | -13.93% |
| 1997 Q3 | 554 Million USD | 15.44% |
| 1997 FY | 539.5 Million USD | 531.73% |
| 1997 Q4 | 539.5 Million USD | -2.62% |
| 1996 FY | 85.4 Million USD | 55.56% |
| 1996 Q1 | 58.1 Million USD | 5.83% |
| 1996 Q2 | 63.2 Million USD | 8.78% |
| 1996 Q3 | 70 Million USD | 10.76% |
| 1996 Q4 | 85.4 Million USD | 22.0% |
| 1995 Q2 | 47.8 Million USD | 11.16% |
| 1995 Q3 | 49.8 Million USD | 4.18% |
| 1995 Q4 | 54.9 Million USD | 10.24% |
| 1995 Q1 | 43 Million USD | 0.7% |
| 1995 FY | 54.9 Million USD | 28.57% |
| 1994 Q4 | 42.7 Million USD | 11.2% |
| 1994 Q3 | 38.4 Million USD | 10.03% |
| 1994 FY | 42.7 Million USD | 38.19% |
| 1994 Q1 | 33 Million USD | 6.8% |
| 1994 Q2 | 34.9 Million USD | 5.76% |
| 1993 Q2 | 21.3 Million USD | -1.39% |
| 1993 FY | 30.9 Million USD | 286.25% |
| 1993 Q1 | 21.6 Million USD | 170.0% |
| 1993 Q4 | 30.9 Million USD | 41.74% |
| 1993 Q3 | 21.8 Million USD | 2.35% |
| 1992 Q4 | 8 Million USD | 0.0% |
| 1992 FY | 8 Million USD | 81.82% |
| 1991 Q4 | 4.4 Million USD | 0.0% |
| 1991 FY | 4.4 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 84.889% |
| Allurion Technologies Inc. | 71.71 Million USD | -15327.958% |
| Artivion, Inc. | 792.39 Million USD | -1296.232% |
| Avanos Medical, Inc. | 1.69 Billion USD | -553.728% |
| Butterfly Network, Inc. | 304.27 Million USD | -3536.097% |
| Butterfly Network, Inc. | 304.27 Million USD | -3536.097% |
| Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 10.044% |
| Boston Scientific Corporation | 35.13 Billion USD | 68.512% |
| CONMED Corporation | 2.3 Billion USD | -381.026% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | -18.161% |
| Paragon 28, Inc. | 340.69 Million USD | -3147.352% |
| Glaukos Corporation | 940.41 Million USD | -1076.471% |
| Globus Medical, Inc. | 5.08 Billion USD | -117.529% |
| Inspire Medical Systems, Inc. | 676.81 Million USD | -1534.68% |
| Integer Holdings Corporation | 2.94 Billion USD | -275.977% |
| Medtronic plc | 89.98 Billion USD | 87.704% |
| Myomo, Inc. | 14.58 Million USD | -75774.536% |
| Nevro Corp. | 635.71 Million USD | -1640.36% |
| Owlet, Inc. | 44.12 Million USD | -24974.671% |
| Penumbra, Inc. | 1.55 Billion USD | -610.895% |
| Vicarious Surgical Inc. | 119.86 Million USD | -9130.208% |
| Smith & Nephew plc | 9.98 Billion USD | -10.781% |
| Sonendo, Inc. | 78.16 Million USD | -14055.191% |
| Stryker Corporation | 39.91 Billion USD | 72.28% |
| Vapotherm, Inc. | 77.61 Million USD | -14154.219% |
| Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 48.534% |